CalciMedica, Inc.

    Jurisdiction
    United States
    ISIN
    US38942Q2021 (CALC)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    1 / 9

    Profile

    CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €0.00
    Gross margin
    0.0%
    EBIT
    -€21.47M
    EBIT margin
    0.0%
    Net income
    -€17.91M
    Net margin
    0.0%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Roberts Eric W CHIEF BUSINESS OFFICER +10K $2.85 +$28.50K
    Roberts Eric W CHIEF BUSINESS OFFICER +3.5K $2.79 +$9.79K
    Roberts Eric W CHIEF BUSINESS OFFICER +3K $2.74 +$8.22K
    Hebbar Sudarshan Chief Medical Officer +9.6K $2.82 +$26.97K
    Hebbar Sudarshan Chief Medical Officer +6K $2.74 +$16.37K

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 35K $67.65K -7.8K Sell

    Add to watchlist

    Notifications